{
    "organizations": [],
    "uuid": "6a5912ab23c1a6f5750b56656b84d690a8800760",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biocept-and-thermo-fisher-scientif/brief-biocept-and-thermo-fisher-scientific-enter-into-technology-and-commercial-collaboration-idUSFWN1RA0JS",
    "ord_in_thread": 0,
    "title": "BRIEF-Biocept And Thermo Fisher Scientific Enter Into Technology And Commercial Collaboration",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - Biocept Inc:\n* BIOCEPT AND THERMO FISHER SCIENTIFIC ENTER INTO TECHNOLOGY AND COMMERCIAL COLLABORATION\n* BIOCEPT INC - ENTERED INTO A NON-BINDING MEMORANDUM OF UNDERSTANDING WITH THERMO FISHER SCIENTIFIC, INC. TO COLLABORATE TOGETHER COMMERCIALLY​\n* BIOCEPT - P‍LAN TO VALIDATE THERMO FISHER’S ONCOMINE NEXT-GENERATION SEQUENCING LIQUID BIOPSY PANELS IN BIOCEPT’S CLIA-CERTIFIED LABORATORY​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-28T20:15:00.000+03:00",
    "crawled": "2018-03-29T15:45:18.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "biocept",
        "inc",
        "biocept",
        "thermo",
        "fisher",
        "scientific",
        "enter",
        "technology",
        "commercial",
        "collaboration",
        "biocept",
        "inc",
        "entered",
        "memorandum",
        "understanding",
        "thermo",
        "fisher",
        "scientific",
        "collaborate",
        "together",
        "biocept",
        "validate",
        "thermo",
        "fisher",
        "oncomine",
        "sequencing",
        "liquid",
        "biopsy",
        "panel",
        "biocept",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}